Back
ADT Vs. Kymera Therapeutics Industry Stock Comparison
Sell
33
ADT
ADT
Last Price:
6.87
Seasonality Move:
11.16%
Buy
54
KYMR
Kymera Therapeutics
Last Price:
45.88
Seasonality Move:
25.63%
Sell
33
ADT (ADT)
is a Sell
Is ADT a Buy, Sell or Hold?
- The current ADT [ADT] share price is $6.90. The Score for ADT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- ADT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $44.77. The Score for KYMR is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ADT Stock Price Chart
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $44.77
The current trend is moderately bearish and KYMR is experiencing selling pressure, which indicates risk of future bearish movement.
ADT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 35.48 | Sell |
Chaikin Money Flow: | -2366481 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.09 - 7.43) | Sell |
Bollinger Bands (100): | (6.86 - 7.6) | Sell |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.88 | Buy |
Relative Strength Index (14 RSI): | 48.13 | Sell |
Chaikin Money Flow: | -245093 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.03 - 48.09) | Sell |
Bollinger Bands (100): | (32.8 - 44.58) | Buy |
ADT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.11 | Sell |
20-day SMA: | 7.28 | Sell |
50-day SMA: | 7.37 | Sell |
200-day SMA: | 6.89 | Buy |
8-day EMA: | 7.1 | Sell |
20-day EMA: | 7.22 | Sell |
50-day EMA: | 7.29 | Sell |
200-day EMA: | 7.01 | Sell |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.33 | Sell |
20-day SMA: | 46.49 | Sell |
50-day SMA: | 43.27 | Buy |
200-day SMA: | 35.7 | Buy |
8-day EMA: | 46.22 | Sell |
20-day EMA: | 45.92 | Sell |
50-day EMA: | 43.32 | Buy |
200-day EMA: | 36.21 | Buy |
ADT Earnings Growth & ADT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.00 per share, an increase this year of $0.33 per share, and an increase next year of $0.16 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.25 per share, and a decrease next year of $0.51 per share.
ADT Technical Analysis
Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |